Indication
Immunosuppressive Agents
2 clinical trials
2 products
Clinical trial
A Phase I Multi-dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) With or Without Recombinant Human Interleukin-2 (rhIL-2) in Adults With Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission With Minimal Residual Disease (MRD) or Relapsed/Refractory (R/R) AMLStatus: Recruiting, Estimated PCD: 2024-06-03
Product
CYNK-001Clinical trial
The Cost-effectiveness Analysis of Immunosuppressants to Postoperative Infection and Death in the Patients With Organ TransplantationStatus: Recruiting, Estimated PCD: 2024-11-20
Product
Immunosuppressive Agents